ask="0.4550"
ask_size="400"
average_daily_volume="1557290"
bid="0.2800"
bid_size="500"
book_value="0.1680"
change="-0.0083"
change_from_200_day_moving_average="-0.0600"
change_from_50_day_moving_average="-0.0174"
change_from_52_week_high="-0.8399"
change_From_52_week_low="0.0101"
change_in_percent="-2.6913%"
close="0.3001"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.2040"
ebitda="-41.64M"
eps_estimate_current_year="-0.1300"
eps_estimate_next_quarter="-0.0300"
eps_estimate_next_year="-0.1100"
ex_dividend_date="N/A"
float_shares="229462000"
high="0.3100"
high_52_weeks="1.1400"
last_trade_date="1/5/2017"
last_trade_price="0.3001"
last_trade_size="10032"
last_trade_time="4:00pm"
low="0.2964"
low_52_weeks="0.2900"
market_capitalization="77.17M"
moving_average_200_day="0.3601"
moving_average_50_day="0.3175"
name="Peregrine Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="1.2500"
open="0.3090"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-16.6558%"
percent_change_from_50_day_moving_average="-5.4803%"
percent_change_from_52_week_high="-73.6754%"
percent_change_from_52_week_low="+3.4828%"
previous_close="0.3084"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.8357"
price_per_sales="1.4559"
revenue="54.47M"
shares_outstanding="257141000"
short_ratio="0.5700"
stock_exchange="NCM"
symbol="PPHM"
volume="2586553"
weeks_range_52="0.2900 - 1.1400"
